Prudent Man Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Prudent Man Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$688	Hold	175	–	–	﹤0.01%	161
2026 Q1	$688	Hold	175	–	–	﹤0.01%	161
2025 Q4	$688	Hold	175	–	–	﹤0.01%	161
2025 Q3	$993	Hold	175	–	–	﹤0.01%	150
2025 Q2	$993	Hold	175	–	–	﹤0.01%	150
2025 Q1	$993	Hold	175	–	–	﹤0.01%	150
2024 Q4	$993	Buy	+175	New	+$1.13K	﹤0.01%	150

Other funds holding VYGR

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Prudent Man Investment Management's VYGR Position: Q2 2026 in Review

Prudent Man Investment Management held its Voyager Therapeutics (VYGR) position steady in Q2 2026 at 175 shares worth $688. The position accounts for ﹤0.01% of the portfolio, ranked #161.

Prudent Man Investment Management first reported a position in VYGR in Q4 2024 and has held it in 7 quarters since. The position peaked at $993 in Q3 2025. 28 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

Prudent Man Investment Management held 175 shares of Voyager Therapeutics worth $688 as of Q2 2026.
Prudent Man Investment Management left its Voyager Therapeutics share count unchanged in Q2 2026.
Voyager Therapeutics made up ﹤0.01% of Prudent Man Investment Management's portfolio in Q2 2026, its #161 holding.
Prudent Man Investment Management first reported a position in Voyager Therapeutics in Q4 2024 and has held it in 7 quarters since.
Prudent Man Investment Management's Voyager Therapeutics position peaked at $993 in Q3 2025.
28 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Prudent Man Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.